Skip to content
Menu

UroGen Pharma Ltd. URGN

Full chart Compare
Set alert

Price alert · URGN

All alert types
31.73 USD +1.94 (+6.51%)

Regular-session close

32.00 +0.27 +0.85%

After hours · Nov 19, 5:27 PM ET

29.23 Day range 32.73
16.50 52-week range 50.81
YTD
+35.48%
1 year
+25.56%

Revenue & Expenses

Revenue Profit Costs
Gross Profit$97.34MNet Loss$153.49MCost of Revenue$12.45MExpenses$250.84MSelling, General & Admin$155.10MResearch & Development$67.11MOther Expenses$28.55MIncome Tax$78.00KRevenue$109.79M

Latest period ending Dec 31, 2025 · select a line to chart its full history

URGN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
109.79M90.40M82.71M64.36M48.04M
97.34M81.52M73.35M56.70M42.88M
-124.86M-96.78M-65.54M-79.04M-92.29M
-153.49M-126.87M-102.24M-109.78M-110.82M
-3.19-2.96-3.55-4.81-4.96
URGN annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
112.09M173.06M95.82M56.22M45.59M
200.46M285.71M178.31M135.62M119.75M
305.93M294.51M243.52M224.98M111.33M
130.09M123.39M99.39M99.12M398.00K
-105.47M-8.80M-65.21M-89.36M8.41M
URGN annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-162.44M-96.77M-76.38M-87.56M-84.89M
61.56M-20.61M-953.00K1.06M4.07M
39.92M194.62M116.93M97.13M72.32M
-289.00K-295.00K-194.00K-254.00K-752.00K
-60.97M77.24M39.60M10.63M-8.50M